2010
Evaluating Interventions to Improve Antiretroviral Adherence: How Much of an Effect Is Required for Favorable Value?
Braithwaite RS, Fiellin DA, Nucifora K, Bryant K, Roberts M, Kim N, Justice AC. Evaluating Interventions to Improve Antiretroviral Adherence: How Much of an Effect Is Required for Favorable Value? Value In Health 2010, 13: 535-542. PMID: 20345544, PMCID: PMC3032536, DOI: 10.1111/j.1524-4733.2010.00714.x.Peer-Reviewed Original ResearchConceptsAbsolute risk reductionNonadherent patientsAdherence interventionsRelative riskRisk factorsAntiretroviral therapy adherence interventionsEffect sizeNonadherence risk factorsBehavioral risk factorsHIV careAntiretroviral adherencePatientsNonadherenceSocietal perspectiveIncremental costIntervention costsSmall effect sizesLife expectancyInterventionRisk reductionPlausible effect sizes
2008
Adjusting Alcohol Quantity for Mean Consumption and Intoxication Threshold Improves Prediction of Nonadherence in HIV Patients and HIV‐Negative Controls
Braithwaite RS, Conigliaro J, McGinnis KA, Maisto SA, Bryant K, Justice AC. Adjusting Alcohol Quantity for Mean Consumption and Intoxication Threshold Improves Prediction of Nonadherence in HIV Patients and HIV‐Negative Controls. Alcohol Clinical And Experimental Research 2008, 32: 1645-1651. PMID: 18616666, PMCID: PMC3111093, DOI: 10.1111/j.1530-0277.2008.00732.x.Peer-Reviewed Original ResearchConceptsMean daily alcohol consumptionProportion of daysDaily alcohol consumptionSignificant nonadherenceAlcohol consumptionCohort studyTimeline FollowbackVeterans Aging Cohort StudyMedication adherence historyMulti-site cohort studyHIV-negative controlsAging Cohort StudyAlcohol-induced cognitive impairmentCross-sectional analysisNonadherence riskHIV patientsUninfected patientsMedication dosesMedication nonadherencePrescribed medicationsAdherence historyNonadherenceUninfected controlsUsual levelStandard drinks